Recombinant human erythropoietin product B
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human erythropoietin product B, covering 2024-08-19 to 2024-08-19. Get the full timeline:
Most recent: Clinical Trial Update: Comparative Study of Two Recombinant Human Erythropoietin Products in Chronic Kidney Disease Patients [Phase 3]